Member Portal

This report explores the intersection between climate and human rights and makes recommendations on taking first steps to create long-term, resilient business strategies that address human rights impacts related to physical climate impacts as well as the transition to a low carbon economy.

In this Guide, three Transform to Net Zero founding members, Unilever, Nike, and Microsoft, all of whom included Scope 3 reduction in their net zero commitments, share their approach of engaging suppliers to bring them along in the decarbonization journey.

After 10 years of implementing the UN Guiding Principles on Business and Human Rights (UNGPs), companies are increasingly expected to address the harms they have caused or contributed to through their business relationships. This brief explains what effective remedy is, the role of business, and five recommendations for companies to improve access.

The Global Business Coalition against Human Trafficking (GBCAT) has released a new toolkit that aims to help businesses that work in corporate supply chains to quickly identify areas of the business which carry the highest risk of modern slavery and develop a plan to identify, prevent, and address risks.

We can see and feel the human rights impacts of products and services. This issue brief explains downstream human rights due diligence, why it’s important, coming advancements, and how to get started.

How can companies determine whether they have caused, contributed, or are directly linked to an adverse impact through their business relationships? A new white paper explores seven questions to help companies determine their connection to negative impacts and how to reframe these questions to identify appropriate actions to prevent and mitigate potential adverse human rights impacts that may occur in the future.

Sustainability reporting and disclosure on environmental, social, and governance (ESG) issues is increasing globally. BSR's new report provides guidance on producing a good sustainability report based on several prominent reporting standards and frameworks.

In recent years, society’s expectations for the biopharmaceutical industry to advance the right to health has broadened. Gathered from BSR’s direct engagement with pharma companies, we share the most relevant, urgent, and probable human rights impacts for the healthcare sector.

The only way for companies to achieve ambitious greenhouse gas emissions reductions targets is to go beyond direct company operations and tackle value chain (Scope 3) emissions.

The BSR tool guides companies through human rights due diligence in situations when very little time is available. The tool also makes specific reference to the Siracusa Principles, adopted by the UN Economic and Social Council in 1984, which describe limitations on the restriction on human rights that governments may apply for reasons of public health or national emergency.